Relationship between ocular signs and quality of life in patients with thyroid-related ophthalmopathy
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [22]
  • |
  • Related [20]
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    AIM: To analyze the relationship between ocular signs and quality of life in patients with thyroid-associated ophthalmopathy(TAO).

    METHODS:A total of 356 patients with TAO who treated at a general hospital in Chengdu from October 2019 to December 2019 were selected. Their basic information and ocular signs(intraocular press, visual acuity, exophthalmos and eyelid retraction)were collected. In addition, the Graves Ophthalmopathy Quality of Life Scale(GO-QOL)was used to evaluate patients' quality of life.

    RESULTS:The median of visual function and social psychology of patients with TAO were 87.50 and 68.75 respectively. It was indicated that TAO patients' visual function scores were related to intraocular pressure, visual acuity and eyelid retraction(all P<0.05), social psychology scores were related to visual acuity(P<0.05), the high intraocular pressure had a significant influence on patients' visual function scores(P=0.001), and different visual acuity had a significant influence on the social psychology scores of patients with TAO(P=0.012).

    CONCLUSION:High intraocular pressure and impaired vision can reduce TAO patients' quality of life. Hence, medical staff should pay attention to the ocular signs during symptom management, especially the high intraocular pressure and low visual acuity, actively treating and preventing adverse ocular signs, so as to improve the quality of life of patients with TAO.

    Reference
    1 Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010; 362(8): 726-738
    2 Hodgson NM, Rajaii F. Current understanding of the progression and management of thyroid associated orbitopathy: a systematic review. Ophthalmol Ther 2020; 9(1): 21-33
    3 Bartalena L, Piantanida E, Gallo D, et al. Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy. Front Endocrinol (Lausanne)2020; 11: 615993
    4 Shan ZY, Chen LL, Lian XL, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 2016; 26(8): 1125-1130
    5 Fan SX, Zeng P, Li ZJ, et al. The clinical features of Graves' orbitopathy with elevated intraocular pressure. J Ophthalmol 2021; 2021: 9879503
    6 Li Q, Ye HJ, Ding YG, et al. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS One 2017; 12(5): e0176064
    7邵毅, 陈偲翊, 廖许琳. 2019甲状腺相关性眼病管理实用指南解读. 国际眼科杂志 2021; 21(8): 1408-1411
    8 Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European thyroid association/European group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy. Eur Thyroid J 2016; 5(1): 9-26
    9张晓茹, 刘智平, 杨淑敏, 等. 甲状腺功能正常的甲状腺相关眼病患者情绪及生活质量的研究. 重庆医学 2013; 42(26): 3122-3124
    10 Törring O, Watt T, Sjölin G, et al. Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves' hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-item short form health status survey. Thyroid 2019; 29(3): 322-331
    11 Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol 1998; 82(7): 773-779
    12 Dolman PJ. Evaluating Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 2012; 26(3): 229-248
    13沈玲, 竺慧, 李萧萧, 等. 甲状腺相关眼病患者生存质量的影响因素研究. 中华眼科杂志 2017; 53(8): 575-582
    14陆士恒, 张忆, 黄晓菁, 等. 甲状腺相关眼病合并高眼压患者视觉相关生存质量及相关因素. 国际眼科杂志 2013; 13(9): 1863-1865
    15 Karhanová M, Kalitová J, Kovárˇ R, et al. Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement. Graefes Arch Clin Exp Ophthalmol 2022\〖Epub ahead of print\〗
    16赵益佳, 周炼红, 胡学敏, 等. 甲状腺相关眼病的眼压特征及不同疗法对眼压的影响. 中国斜视与小儿眼科杂志 2021; 29(4): 6-10
    17 Kim JW, Ko J, Woo YJ, et al. Prevalence of ocular hypertension and glaucoma as well as associated factors in Graves' orbitopathy. J Glaucoma 2018; 27(5): 464-469
    18钟思思, 刘泽阳, 吴旭昇, 等. 甲状腺相关眼病患者生活质量下降相关因素分析. 国际眼科杂志 2017; 17(2): 311-316
    19 Wang Y, Sharma A, Padnick-Silver L, et al. Physician-perceived impact of thyroid eye disease on patient quality of life in the United States. Ophthalmol Ther 2021; 10(1): 75-87
    20许诺, 黄丹平, 宋亦悦, 等. 甲状腺相关眼病患者眼表损害与相关因素分析. 中山大学学报(医学科学版)2010; 31(6): 833-837
    21牟稀, 魏锐利. 甲状腺相关眼病上脸退缩的诊断和治疗. 中华实验眼科杂志 2017; 35(3): 286-288
    22杨梅, 王钰娇, 何为民. 甲状腺相关眼病的影像学检查. 国际眼科杂志 2021; 21(6): 1025-1028
    Cited by
Get Citation

Xu-Jia Xiao, Yu-Ping Shui, Xian-Qiong Feng. ,/et al.Relationship between ocular signs and quality of life in patients with thyroid-related ophthalmopathy. Guoji Yanke Zazhi( Int Eye Sci) 2022;22(12):2099-2104

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:February 27,2022
  • Revised:November 17,2022
  • Online: November 29,2022